SLAB SILICON LABORATORIES INC.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1038074 · Fiscal year ends 01/02
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY21.3%
TTM net income YoY76.4%
TTM EPS YoY77.2%
Revenue 3-yr CAGR-1.9%
Net income 3-yr CAGR—
Margins
Gross margin61.3%
Operating margin-2.6%
Net margin-2.3%
FCF margin0.8%
EBITDA margin0.1%
Returns
ROE-1.9%
ROA-1.6%
ROIC (approx.)-2.5%
Asset turnover0.70x
Leverage & solvency
Liabilities / assets15.8%
Debt / equity0.00x
Current ratio4.60x
Interest coverage-24.97x
Cash quality & payout
Operating cash flow / net income-2.24x
Accruals ratio-5.1%
Payout ratio—
Capex / revenue4.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252026-01-03 | FY20242024-12-28 | FY20232023-12-30 | FY2022*2022-12-31 | FY2021*2022-01-01 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $784.76M | $584.39M | $782.26M | $1.02B | $720.86M |
| Cost of revenue | $327.78M | $272.20M | $321.67M | $381.55M | $295.47M |
| Gross profit | $456.98M | $312.19M | $460.59M | $642.56M | $425.39M |
| R&D expense | $353.25M | $332.23M | $337.74M | $332.33M | $273.21M |
| SG&A expense | $174.28M | $145.45M | $147.00M | $190.97M | $185.02M |
| Operating income | -$70.54M | -$165.49M | -$24.15M | $119.26M | -$32.84M |
| Interest expense | $975,000 | $1.31M | $5.55M | $6.72M | $31.03M |
| Pretax income | -$57.91M | -$154.81M | -$26.57M | $129.85M | -$44.45M |
| Income tax | $7.00M | $36.20M | $7.94M | $38.45M | $13.43M |
| Net income | -$64.91M | -$191.01M | -$34.52M | $91.40M | $2.12B |
| EBITDA | -$45.83M | -$139.94M | $1.55M | $141.78M | -$14.79M |
| EPS (basic) | -1.98 | -5.93 | -1.09 | 2.61 | 49.44 |
| EPS (diluted) | -1.98 | -5.93 | -1.09 | 2.54 | 47.78 |
| Weighted avg. shares (diluted) | 32.72M | 32.19M | 31.80M | 36.04M | 44.31M |
| Balance sheet | |||||
| Cash & equivalents | $364.22M | $281.61M | $227.50M | $499.92M | $1.07B |
| Short-term investments | $79.40M | $100.55M | $211.72M | $692.02M | $964.58M |
| Receivables | $64.51M | $54.48M | $29.30M | $71.44M | $98.31M |
| Inventory | $95.57M | $105.64M | $194.29M | $100.42M | $49.31M |
| Current assets | $674.02M | $602.03M | $737.93M | $1.46B | $2.24B |
| PP&E, net | $128.64M | $132.14M | $145.89M | $152.02M | $146.52M |
| Goodwill | $376.39M | $376.39M | $376.39M | $376.39M | $376.39M |
| Intangibles | $23.13M | $36.50M | $59.53M | $84.91M | $118.98M |
| Total assets | $1.27B | $1.22B | $1.44B | $2.17B | $2.96B |
| Current liabilities | $143.79M | $97.88M | $163.57M | $185.78M | $668.83M |
| Total liabilities | $174.90M | $142.65M | $234.37M | $764.42M | $745.87M |
| Shareholders' equity | $1.09B | $1.08B | $1.21B | $1.41B | $2.21B |
| Shares outstanding | 32.95M | 32.46M | 31.90M | 31.99M | 38.48M |
| Cash flow statement | |||||
| Operating cash flow | $95.71M | -$13.91M | -$30.35M | $141.27M | $91.20M |
| Capital expenditure | $29.92M | $11.75M | $22.28M | $26.52M | $28.58M |
| Free cash flow | $65.79M | -$25.66M | -$52.63M | $114.75M | $62.62M |
| Investing cash flow | -$12.03M | $113.12M | $469.81M | $240.54M | -$476.67M |
| Financing cash flow | -$1.07M | -$45.10M | -$711.87M | -$887.05M | -$1.30B |
| Depreciation & amortization | $24.72M | $25.55M | $25.71M | $22.52M | $18.05M |
| Stock-based compensation | $80.32M | $61.50M | $48.21M | $60.51M | $56.84M |
| Share buybacks | $0 | $16,000 | $217.14M | $883.42M | $1.15B |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.